Trellus Health plc
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TRLS.L research report →
Companywww.trellushealth.com
Trellus Health plc provides digital chronic condition management solutions for employers and health plans. The company offers TrellusElevate, a proprietary HIPAA-compliant technology platform to coordinate and deliver personalized care remotely through telemedicine. Its platform provides patients with access to a care team, educational content resources, and remote monitoring capabilities for the treatment of inflammatory bowel diseases, which include the chronic incurable conditions of Crohn's Disease and ulcerative colitis.
- CEO
- Marla Cindy Dubinsky
- IPO
- 2021
- Employees
- 31
- HQ
- White Plains, NY, US
Price Chart
Valuation
- Market Cap
- $188.16K
- P/E
- -0.04
- P/S
- 0.70
- P/B
- 0.03
- EV/EBITDA
- 0.19
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 100.00%
- Op Margin
- -1946.52%
- Net Margin
- -1918.66%
- ROE
- -67.29%
- ROIC
- -80.27%
Growth & Income
- Revenue
- $114.00K · 500.00%
- Net Income
- $-7,782,000 · -22.76%
- EPS
- $-0.05 · -22.96%
- Op Income
- $-8,027,000
- FCF YoY
- -3.10%
Performance & Tape
- 52W High
- $2.34
- 52W Low
- $0.10
- 50D MA
- $0.19
- 200D MA
- $0.52
- Beta
- 2.59
- Avg Volume
- 12.56M
Get TickerSpark's AI analysis on TRLS.L
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our TRLS.L Coverage
We haven't published any research on TRLS.L yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate TRLS.L Report →